Citations

Clear

3138 citation(s) found for "Smith, AM".

Giant Cell Arteritis
Swanson, Jerry W., Smith, Jonathan H.

Mayo Clinic

Headache: The Journal of Head and Face Pain | July 18, 2014 | Volume: 54 | Issue: 8 | Pages: 1273-1289

10.1111/head.12425 | PMID 25041449 Get It

Giant cell arteritis ( GCA ) is a medium and large‐vessel vasculitis, which is an important cause of secondary headache in older adults. While GCA has a classic presentation occurring after the age of 50, atypical presentations (eg, fever of unknown origin, cough, low or normal erythrocyte sedimentation rate) may lead to a delay in diagnosis. The topography of vascular involvement has implications for disease‐related complications, which can result in neurologic disease at multiple levels of the nervous system. The most feared complication, vision loss, fortunately becomes uncommon after initiation of corticosteroids. Corticosteroid treatment should not be withheld while waiting the results of a temporal artery biopsy ( TAB ), which remains the gold standard for GCA diagnosis. Newer diagnostic modalities, including ultrasound, magnetic resonance imaging, and positron emission tomography can play an important role in directing treatment in cases with negative TAB . After successful control of the disorder, patients should be gradually tapered off corticosteroids, with careful monitoring using both clinical and laboratory parameters to assess for relapse. Corticosteroid‐related treatment complications are not uncommon in GCA . There is mixed evidence for use of adjunct corticosteroid‐sparing agents (eg, methotrexate), although these should be initiated in the setting of corticosteroid‐related morbidity and/or cases with frequent relapse.
MRS in Mild Cognitive Impairment: Early Differentiation of Dementia with Lewy Bodies and Alzheimer's Disease
Ferman, Tanis J. , Smith, Glenn E. , Maroney‐Smith, Mandie, Spychalla, Anthony J., Jack, Clifford R. , Petersen, Ronald C. , Kantarci, Kejal , Maroney-Smith, Mandie, Zhang, Bing , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R , Kantarci, Kejal , Ferman, Tanis J

Mayo Clinic

Journal of Neuroimaging | July 16, 2014 | Volume: 25 | Issue: 2 | Pages: 269-274

10.1111/jon.12138 | PMID 25039916 Get It

ABSTRACTBACKGROUND AND PURPOSEMild cognitive impairment (MCI) precedes both Alzheimer's disease (AD) dementia and with Lewy bodies (DLB). We investigated proton magnetic resonance spectroscopy (MRS) characteristics of MCI patients who progressed to DLB compared to those who progressed to AD dementia or remained stable.METHODSConsecutive MCI patients who underwent single voxel MRS at baseline and progressed to DLB (n = 10) were identified during a median follow‐up period of 18 months. From the same cohort, we identified age‐ and sex‐matched MCI patients who progressed to AD dementia (n = 27) or remained stable (n = 20) during a similar follow‐up period. This study was approved by the Institutional Review Board and informed consent was from every subject.RESULTSMCI patients who progressed to AD dementia were characterized by lower N‐acetylaspartate (NAA)/Cr ratio in the posterior cingulate voxel compared to those who progressed to DLB (P = .001). Decreased NAA/Cr in the posterior cingulate voxel differentiated MCI patients who progressed to DLB from those who progressed to AD with an area under the receiver operating characteristic curve of .85 (P < .001) on logistic regression analysis.CONCLUSIONSMRS may be useful in differentiating MCI patients with prodromal AD dementia from those with prodromal DLB for early disease‐specific interventions.
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS
Zeidan, Amer M. , Lee, Ju‐Whei, Prébet, Thomas , Greenberg, Peter L. , Sun, Zhuoxin , Juckett, Mark, Smith, Mitchell R. , Paietta, Elisabeth , Gabrilove, Janice , Katterling, Rhett P., Tallman, Martin S. , Gore, Steven D. , Lee, Ju‐Whei , Erba, Harry Paul , Prebet, Thomas , Zeidan, Amer M

Mayo Clinic

British Journal of Haematology | July 4, 2014 | Volume: 167 | Issue: 1 | Pages: 62-68

10.1111/bjh.13008 | PMID 24995683 Get It

SummaryReliable clinical or molecular predictors of benefit from azacitidine therapy in patients with myelodysplastic syndromes (MDS) are not defined. Doubling of platelet count at start of second cycle of azacitidine therapy compared to baseline was associated with achieving response and survival advantage in a Dutch cohort. To validate this observation, we analysed a larger cohort of North American patients, whose data was collected in a prospective clinical trial with a longer median follow‐up. We found a significant association between platelet count doubling after first cycle of azacitidine therapy and probability of achieving objective response. Among patients with MDS or oligoblastic acute myeloid leukaemia (<30% bone marrow blasts, n = 102), there was a statistically significant reduction in risk of death for patients who achieved platelet count doubling (n = 23, median OS, 21·0 months) compared to those who did not (n = 79, median OS, 16·7 months, adjusted hazard ratio (no/yes)=1·88, 95% confidence interval, 1·03–3·40, P = 0·04). Nonetheless, the addition of this platelet count doubling variable did not improve the survival prediction provided by the revised International Prognostic Scoring System or the French Prognostic Scoring System. Identification of reliable and consistent predictors for clinical benefit for azacitidine therapy remains an unmet medical need and a top research priority.
Left Atrial Appendage Aneurysm: A Systematic Review of 82 Cases
Aryal, Madan Raj , Hakim, Fayaz A., Ghimire, Sailu, Ghimire, Sushil , Pandit, Anil , Bhandari, Yashoda, Bhandari, Naresh, Pathak, Ranjan , Karmacharya, Paras , Pradhan, Rajesh , Giri, Smith , Karmacharya, Paras

Mayo Clinic

Echocardiography | June 28, 2014 | Volume: 31 | Issue: 10 | Pages: 1312-1318

10.1111/echo.12667 | PMID 24976376 Get It

BackgroundAneurysm of the left atrial appendage is rare. We sought to systematically review the published literature on left atrial appendage aneurysm (LAAA) to address its demographic features, clinical characteristics, treatment, complications, and outcomes.MethodologyA systematic electronic search of Medline, PubMed, and EMBASE for case reports, case series, and related articles of LAAA published from 1962 until July 2013 was carried out. Statistical analysis was done using SPSS version 20.0. Logistic Regression Analysis was used to identify the independent predictors of LAAA‐related thrombus formation and embolism.ResultsEighty‐two cases of LAAA were identified. There was a slight female preponderance and most of the patients presented in their third decades. Palpitation, dyspnea or both were most common clinical symptoms associated with LAAA. Echocardiography was the main diagnostic modality used and the mean size of aneurysm was 7.08 ± 3.03 × 5.75 ± 2.36 cm. Surgical resection of the aneurysm was performed in most patients with favorable results. Systemic embolism and atrial tachyarrhythmias were the two common complications associated with untreated LAAA. Presence of atrial fibrillation/flutter was the only significant predictor of thrombus formation/embolic events.ConclusionAneurysm of left atrial appendage is rare and often an incidental diagnosis during echocardiography. It is important to recognize this entity since it is associated with cardiovascular morbidity and mortality by predisposing to atrial tachyarrhythmia and thromboembolism. Surgical resection is the standard of treatment in the current literature. Medical management is directed toward the treatment of thromboembolism and atrial tachyarrhythmia.
High‐Resolution Molecular Validation of Self‐Renewal and Spontaneous Differentiation in Clinical‐Grade Adipose‐Tissue Derived Human Mesenchymal Stem Cells
Dudakovic, Amel , Camilleri, Emily T. , Riester, Scott M. , Lewallen, Eric A. , Kvasha, Sergiy M., Chen, Xiaoyue , Radel, Darcie J., Anderson, Jarett M., Nair, Asha, Evans, Jared M., Krych, Aaron J. , Smith, Jay , Deyle, David R. , Stein, Janet L. , Im, Hee‐Jeong , Cool, Simon M. , Dietz, Allan B. , Wijnen, André J. van , Camilleri, Emily , Stein, Gary S. , Westendorf, Jennifer J. , Kakar, Sanjeev , van Wijnen, Andre J , Krych, Aaron J , Dietz, Allan B , Camilleri, Emily

Mayo Clinic

Journal of Cellular Biochemistry | June 6, 2014 | Volume: 115 | Issue: 10 | Pages: 1816-1828

10.1002/jcb.24852 | PMID 24905804 Get It

AbstractImproving the effectiveness of adipose‐tissue derived human mesenchymal stromal/stem cells (AMSCs) for skeletal therapies requires a detailed characterization of mechanisms supporting cell proliferation and multi‐potency. We investigated the molecular phenotype of AMSCs that were either actively proliferating in platelet lysate or in a basal non‐proliferative state. Flow cytometry combined with high‐throughput RNA sequencing (RNASeq) and RT‐qPCR analyses validate that AMSCs express classic mesenchymal cell surface markers (e.g., CD44, CD73/NT5E, CD90/THY1, and CD105/ENG). Expression of CD90 is selectively elevated at confluence. Self‐renewing AMSCs express a standard cell cycle program that successively mediates DNA replication, chromatin packaging, cyto‐architectural enlargement, and mitotic division. Confluent AMSCs preferentially express genes involved in extracellular matrix (ECM) formation and cellular communication. For example, cell cycle‐related biomarkers (e.g., cyclins E2 and B2, transcription factor E2F1) and histone‐related genes (e.g., H4, HINFP, NPAT) are elevated in proliferating AMSCs, while ECM genes are strongly upregulated (>10‐fold) in quiescent AMSCs. AMSCs also express pluripotency genes (e.g., POU5F1, NANOG, KLF4) and early mesenchymal markers (e.g., NES, ACTA2) consistent with their multipotent phenotype. Strikingly, AMSCs modulate expression of WNT signaling components and switch production of WNT ligands (from WNT5A/WNT5B/WNT7B to WNT2/WNT2B), while upregulating WNT‐related genes (WISP2, SFRP2, and SFRP4). Furthermore, post‐proliferative AMSCs spontaneously express fibroblastic, osteogenic, chondrogenic, and adipogenic biomarkers when maintained in confluent cultures. Our findings validate the biological properties of self‐renewing and multi‐potent AMSCs by providing high‐resolution quality control data that support their clinical versatility. J. Cell. Biochem. 115: 1816–1828, 2014. © 2014 Wiley Periodicals, Inc.
Neural Autoantibody Clusters Aid Diagnosis of Cancer
Horta, Erika , Lennon, Vanda A. , Jenkins, Sarah M. , McKeon, Andrew , Klein, Christopher J. , Pittock, Sean J. , Smith, Carin Y. , Lachance, Daniel Honore , Pittock, S J , Klein, Christopher J , McKeon, Andrew

Mayo Clinic

Clinical Cancer Research | May 16, 2014 | Volume: 20 | Issue: 14 | Pages: 3862-3869

10.1158/1078-0432.ccr-14-0652 | PMID 24833664 Get It

Abstract Purpose: Clustering of neural autoantibodies in patients with paraneoplastic neurologic disorders may predict tumor type. A mathematical analysis of neural autoantibody clusters was performed in 78,889 patients undergoing evaluation for a suspected paraneoplastic autoimmune neurologic disorder. Tumor predictive autoantibody profiles were confirmed in sera from patients with histologically proven tonsillar cancer, thymoma, and lung cancer. Patients and Methods: Of note, 78,889 patient sera were tested for 15 defined neural autoantibodies (1.2 million tests). The observed and hypothesized frequencies of autoantibody clusters were compared and their tumor associations defined. A tumor validation study comprised serum from 368 patients with a variety of tumors (thymoma, lung, or tonsil). Results: Informative oncological associations included (i) thymoma in 85% of patients with muscle striational, acetylcholine receptor antibodies plus CRMP5 autoantibodies; (ii) lung carcinoma in 80% with both P/Q-type and N-type calcium channel antibodies plus SOX1-IgG; and (iii) in men, prostate carcinoma frequency more than doubled when striational and muscle AChR specificities were accompanied by ganglionic AChR antibody. In women, amphiphysin-IgG alone was associated commonly with breast carcinoma, but amphiphysin-IgG, coexisting with antineuronal nuclear autoantibody-type 1 or CRMP5-IgG, was associated with lung cancer (P &lt; 0.0001). In the validation cohorts, many tumor-associated profiles were encountered that matched the clusters identified in the screening study (e.g., 15% of thymoma patients had striational, acetylcholine receptor antibodies plus collapsin response-mediator protein-5 autoantibodies). Conclusions: Neural autoantibodies commonly coexist in specific clusters that are identifiable by comprehensive screening. Signature autoantibody clusters may predict a patient's cancer risk and type. Clin Cancer Res; 20(14); 3862–9. ©2014 AACR.
Hepatic Uterus-Like Mass Misdiagnosed as Hepatic Abscess
Sopha, Sabrina C., Rosado, Flavia, Smith, J. Joshua , Merchant, Nipun B. , Shi, Chanjuan , Rosado, Flavia G N, Smith, J Joshua

Mayo Clinic

International Journal of Surgical Pathology | May 14, 2014 | Volume: 23 | Issue: 2 | Pages: 134-139

10.1177/1066896914534465 | PMID 24827588 Get It

Background. Hepatic endometriosis/uterus-like mass is rare and may be overlooked during hepatic cyst workups. We report a case of uterus-like mass, misdiagnosed as hepatic abscess. Case Report: A 47-year-old woman developed abdominal pain and vomiting. Infectious colitis with hepatic abscess was diagnosed, and remained antibiotic-refractory. Fine-needle aspiration and core biopsies showed benign contents. The patient presented to our institution with symptoms and normal blood work. Laparoscopic excision demonstrated a 1.4-cm cyst composed of endometrial glands (estrogen receptor+ and progesterone receptor+) and stroma (CD10+) with smooth muscle actin (SMA+), arranged in an organoid fashion. The patient, status-post hysterectomy, had no history or symptoms of endometriosis. Conclusion. This rare case illustrates the merit of considering uterus-like mass/endometriosis in the differential diagnosis of antibiotic-refractory hepatic cysts. Cyst heterogeneity may confound needle biopsy. We report the first instance of a hepatic uterus-like mass, with a review of related entities, postulated histogenesis, and important clinical associations.
The effect of magnification on sonographically measured nerve cross‐sectional area
Jelsing, Elena J., Presley, James C., Maida, Eugene , Hangiandreou, Nicholas J., Smith, Jay

Mayo Clinic

Muscle & Nerve | May 3, 2014 | Volume: 51 | Issue: 1 | Pages: 30-34

10.1002/mus.24274 | PMID 24796756 Get It

ABSTRACTIntroduction: The primary aim of this investigation was to determine whether use of write‐zoom magnification affects sonographically determined cross‐sectional area (CSA) of peripheral nerves. Methods: CSAs of the median (MN) and posterior interosseous (PIN) nerves were measured in 22 limbs from 11 asymptomatic volunteers using both standard imaging and write‐zoom magnification. CSA measurements were repeated on the same images 1 week later. Results: The average CSA of write‐zoomed images for the MN was significantly larger at both measurement sessions (week 1: 11.1 mm2 write‐zoom vs. 10.0 mm2 standard, P = 0.019; week 2: 11.8 mm2 vs. 10.4 mm2, P = 0.023). Similar differences were noted for the PIN (week 1: 2.3 mm2 vs. 1.9 mm2, P = 0.002; week 2: 2.5 mm2 vs. 1.9 mm2, P = 0.001). Conclusions: Write‐zoom magnification may significantly increase the measured CSA of peripheral nerves. These changes appear to be more substantial when smaller nerves are measured. Muscle Nerve 51: 30–34, 2015
The Effect of Saccadic Training on Early Reading Fluency
Leong, Danielle, Master, Christina L. , Messner, Leonard V., Starling, Amaal J. , Pang, Yi , Smith, Craig E.

Mayo Clinic

Clinical Pediatrics | May 1, 2014 | Volume: 53 | Issue: 9 | Pages: 858-864

10.1177/0009922814532520 | PMID 24790022 Get It

Background . Eye movements are necessary for the physical act of reading and have been shown to relate to underlying cognitive and visuoattentional processes during reading. The purpose of this study was to determine the effect of saccadic training using the King-Devick remediation software on reading fluency. Methods . In this prospective, single-blinded, randomized, crossover trial, a cohort of elementary students received standardized reading fluency testing pre- and posttreatment. Treatment consisted of in-school training 20 minutes per day, 3 days per week for 6 weeks. Results . The treatment group had significantly higher reading fluency scores after treatment ( P < .001), and posttreatment scores were significantly higher than the control group ( P < .005). Conclusion . Saccadic training can significantly improve reading fluency. We hypothesize that this improvement in reading fluency is a result of rigorous practice of eye movements and shifting visuospatial attention, which are vital to the act of reading.
Mycobacterium arupense Flexor Tenosynovitis: Case Report and Review of Antimicrobial Susceptibility Profiles for 40 Clinical Isolates
Beam, Elena , Vasoo, Shawn , Simner, Patricia J. , Rizzo, Marco , Mason, Erin L., Walker, Randall C., Deml, Sharon M., Brown‐Elliott, Barbara A. , Wallace, Richard J. , Wengenack, Nancy L. , Sia, Irene G. , Beam, Elena , Sia, Irene G

Mayo Clinic

Journal of Clinical Microbiology | May 1, 2014 | Volume: 52 | Issue: 7 | Pages: 2706-2708

10.1128/jcm.00277-14 | PMID 24789193 Get It

ABSTRACT We describe a case of chronic tenosynovitis in the hand of a 58-year-old cattle farmer. Surgical biopsy specimens grew Mycobacterium arupense . The patient responded to surgery and antimicrobial therapy based on in vitro susceptibility testing. The antimicrobial susceptibility profiles of the isolate from this patient and 39 additional clinical isolates are presented.